The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.
about
DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virusChorioretinal post-transplant lymphoproliferative disorder induced by the Epstein-Barr virusCurrent status of renal transplantation.Late complications after cardiac transplantationEither ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.The Epstein-Barr virus and its association with human cancers.High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders.Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders.Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy.Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.Multivisceral intestinal transplantation: surgical pathology.Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppressionEpstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.Non-Hodgkin's lymphoma revealed by an ilio-colic intussusception in a Moroccan patient: a case reportThe mother lode of liver transplantation, with particular reference to our new journal.Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders.Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune diseaseHerpesvirus infections in organ transplant recipientsEvaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review.Infections in solid-organ transplant recipientsLymphoproliferative disorders in Oxford renal transplant recipientsInterleukin-6 production in posttransplant lymphoproliferative disease.Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disordersInterleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease.The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disordersPost-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient originExpression of p16/INK4a in posttransplantation lymphoproliferative disorders.Molecular genetic analysis of lymphoid tumors arising after organ transplantation.AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridizationThe systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study.Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice.Characterization of clonality of Epstein-Barr virus-induced human B lymphoproliferative disease in mice with severe combined immunodeficiency.Two cases of post transplant lymphoproliferative disorder in lung transplant recipients.Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genesEpstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment
P2860
Q27023922-E56C1437-81E5-4FF9-B095-D28FE8F9FFA1Q28345368-6E5DD461-1EAF-4938-BDDE-3713CFC56343Q33558294-C7908B7C-3002-4DBD-8CB6-2A2760A93CD9Q33613810-D1A215C7-25AC-4630-8A91-9C3510022B2DQ33877497-3EDCE248-BED8-4DA2-A0A6-3EC6DA9AE8B6Q33882153-B1B8B3CF-7786-456B-8B1C-196B12ADA441Q33965341-B99344B0-A439-48C0-B92C-4F0EE549A07CQ33974645-B6BEAEAD-36CC-44F9-B883-A1D1BD8B4116Q34078707-7D1CD709-9F5A-4007-B9AF-2753CB20757DQ34120915-E72A59C9-98CE-4A1E-9787-C451CC9B76C6Q34207259-EC171E26-E9BF-42F8-8DA5-B03E754FC571Q34235300-00970EB6-5BC2-40E2-98E5-544FCB83E29CQ34236993-06D934AF-4B7A-4ECC-8A70-44658F5ACA4DQ34240290-FF8E279F-2DAA-498B-B933-7A8209D978A2Q34275845-83693AFB-4F47-44D0-BF3A-AAEDD69570D2Q34287283-305074FA-139F-4861-AD28-0083951665B2Q34302121-B387305C-7012-46DF-8270-06530504F6C5Q34321109-82A8A128-7E86-4386-91FF-BA09B3D178FEQ34359339-8B7E589D-418B-4D9C-B475-9C838148470EQ34427085-397DA2FA-2E28-4936-9104-9FDA43F1A83AQ34477808-8A251585-503F-4794-B080-9FF8CE16FF56Q34579836-918ECED0-121F-453E-8D1A-4F778B8AF3BBQ34946254-93FE89E7-86D7-4A84-A06A-9B255DEA4202Q34981101-C47D4B7C-95B9-4166-989A-742669179877Q35376486-6C670D19-A1F7-4BB2-8CD3-7538D37199B7Q35586818-89F624B1-9868-43E1-A1E1-AA47DD640D93Q35611724-0587C9B8-2F89-4EF8-AB3D-4DE24BEB1E3AQ35763494-57074C61-07FF-4028-BC62-47A1D8044D38Q35787184-777539E2-2B28-4DEC-985A-8A65933AFE71Q35795114-9B8DC4E1-72E9-43AA-B097-544F34DA91F2Q35796427-ABB6962A-008B-4474-BB00-1F74E02B13BCQ35810155-FF55B1EB-6DAC-47E1-AA70-2E65BC6A3903Q35818174-8FA0CAF0-BF42-4AFF-8388-D75CAFAAA0E8Q35830350-5FB2F832-EC3D-4AD3-BE48-4E46B970D63CQ35830515-92A6D619-AE32-4BDB-9E6C-3C426D68DC4DQ35832279-592F2223-4795-4A12-9A79-08F95E5668EFQ35832561-8A9F25BF-9E4F-4B71-ABF7-9F25CE8FBD3CQ35936913-475D16D3-CF52-4703-A9BE-C80799C3D9BFQ36048272-238F6F32-4E56-4CC9-AA56-D09F388D0DEEQ36170494-498F3D97-CEE7-4435-941E-11586360A3F9
P2860
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The pathology of posttransplan ...... -prednisone immunosuppression.
@ast
The pathology of posttransplan ...... -prednisone immunosuppression.
@en
type
label
The pathology of posttransplan ...... -prednisone immunosuppression.
@ast
The pathology of posttransplan ...... -prednisone immunosuppression.
@en
prefLabel
The pathology of posttransplan ...... -prednisone immunosuppression.
@ast
The pathology of posttransplan ...... -prednisone immunosuppression.
@en
P2093
P2860
P1476
The pathology of posttransplan ...... -prednisone immunosuppression.
@en
P2093
Burnham JA
Nalesnik MA
P2860
P304
P407
P577
1988-10-01T00:00:00Z